BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9300661)

  • 81. Multiple sclerosis: does epidemiology contribute to providing etiological clues?
    Granieri E; Casetta I; Tola MR; Govoni V; Paolino E; Malagù S; Monetti VC; Carreras M
    J Neurol Sci; 1993 Apr; 115 Suppl():S16-23. PubMed ID: 8340788
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Epidemiology of multiple sclerosis in Arabs in Jordan: a comparative study between Jordanians and Palestinians.
    Najim Al-Din AS; Kurdi A; Mubaidin A; El-Khateeb M; Khalil RW; Wriekat AL
    J Neurol Sci; 1996 Feb; 135(2):162-7. PubMed ID: 8867073
    [TBL] [Abstract][Full Text] [Related]  

  • 83. HLA and MS.
    Hillert J; Olerup O
    Neurology; 1993 Nov; 43(11):2426-7. PubMed ID: 8232981
    [No Abstract]   [Full Text] [Related]  

  • 84. The inheritance of MS susceptibility.
    Lord D; O'Farrell AG; Staunton H; Keelan E
    Ir J Med Sci; 1990 Jan; 159 Suppl 8():1-20. PubMed ID: 2190946
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The influence of gender on the susceptibility to multiple sclerosis in sibships.
    Sadovnick AD; Bulman DE; Hashimoto L; D'Hooghe MB; Ebers GC
    Arch Neurol; 1991 Jun; 48(6):586-8. PubMed ID: 2039379
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Multiple sclerosis in twins and their relatives: genetic analysis of family histories.
    MYRIANTHOPOULOS NC; MACKAY RP
    Acta Genet Stat Med; 1960; 10():33-47. PubMed ID: 13727272
    [No Abstract]   [Full Text] [Related]  

  • 87. Multiple sclerosis. Hopeful genes and immunology.
    McFarlin DE; Lachmann PJ
    Nature; 1989 Oct; 341(6244):693-4. PubMed ID: 2797205
    [No Abstract]   [Full Text] [Related]  

  • 88. Multiple sclerosis: risk factors, prodromes, and potential causal pathways.
    Ramagopalan SV; Dobson R; Meier UC; Giovannoni G
    Lancet Neurol; 2010 Jul; 9(7):727-39. PubMed ID: 20610348
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Genetic epidemiology of multiple sclerosis.
    Sadovnick AD; Dyment D; Ebers GC
    Epidemiol Rev; 1997; 19(1):99-106. PubMed ID: 9360907
    [TBL] [Abstract][Full Text] [Related]  

  • 90. MS in twins.
    Kahana E; Alter M
    Neurology; 1981 Nov; 31(11):1497. PubMed ID: 7198198
    [No Abstract]   [Full Text] [Related]  

  • 91. Dissecting the familial risk of multiple sclerosis.
    Hardy J; Thompson AJ
    Ann Neurol; 2011 Jan; 69(1):11-2. PubMed ID: 21280071
    [No Abstract]   [Full Text] [Related]  

  • 92. Multiple sclerosis. A cluster in a small Northwestern United States community.
    Koch MJ; Reed D; Stern R; Brody JA
    JAMA; 1974 Jun; 228(12):1555-7. PubMed ID: 4406706
    [No Abstract]   [Full Text] [Related]  

  • 93. Familial and conjugal multiple sclerosis.
    Schapira K; Poskanzer DC; Miller H
    Acta Neurol Scand; 1966; 42(S19):83-84. PubMed ID: 5909425
    [No Abstract]   [Full Text] [Related]  

  • 94. Prime time for multiple sclerosis genetics.
    Bradbury J
    Lancet Neurol; 2005 Nov; 4(11):698-9. PubMed ID: 16265789
    [No Abstract]   [Full Text] [Related]  

  • 95. Cellular and Molecular Evidence of Multiple Sclerosis Diagnosis and Treatment Challenges.
    Khan Z; Gupta GD; Mehan S
    J Clin Med; 2023 Jun; 12(13):. PubMed ID: 37445309
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The gut microbiome molecular mimicry piece in the multiple sclerosis puzzle.
    Elsayed NS; Aston P; Bayanagari VR; Shukla SK
    Front Immunol; 2022; 13():972160. PubMed ID: 36045671
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Impact of IL-21 Gene Polymorphisms (rs2055979) and the Levels of Serum IL-21 on the Risk of Multiple Sclerosis.
    Ali Abdulla A; Abdulaali Abed T; Razzaq Abdul-Ameer W
    Arch Razi Inst; 2022 Feb; 77(1):81-86. PubMed ID: 35891764
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Clinical and transcriptional recovery profiles in pediatric and adult multiple sclerosis patients.
    Menascu S; Khavkin Y; Zilkha-Falb R; Dolev M; Magalashvili D; Achiron A; Gurevich M
    Ann Clin Transl Neurol; 2021 Jan; 8(1):81-94. PubMed ID: 33197148
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf Region.
    Alroughani R; Inshasi J; Al-Asmi A; Alkhabouri J; Alsaadi T; Alsalti A; Boshra A; Canibano B; Ahmed SF; Shatila A
    Neurol Ther; 2020 Dec; 9(2):265-280. PubMed ID: 32564333
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Genome-wide association studies of multiple sclerosis.
    Cotsapas C; Mitrovic M
    Clin Transl Immunology; 2018; 7(6):e1018. PubMed ID: 29881546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.